Advertisement
Screener

AGENUS INC (AGEN) Net Income (Loss) Available to Common Stockholders, Basic

2.8 / 5 stars · 68/120 Roast Me

AGENUS INC Net Income (Loss) Available to Common Stockholders, Basic

AGENUS INC (AGEN) reported Net Income (Loss) Available to Common Stockholders, Basic of -$604.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-07

  • AGENUS INC net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$604.00K.
  • AGENUS INC net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was $39.17M.
  • AGENUS INC net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was -$10.63M.
  • AGENUS INC net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was $63.86M.
  • AGENUS INC net income (loss) available to common stockholders, basic for fiscal 2025 was -$101.00K.
  • AGENUS INC net income (loss) available to common stockholders, basic for fiscal 2024 was -$227.43M.
  • AGENUS INC net income (loss) available to common stockholders, basic for fiscal 2023 was -$245.97M.
  • AGENUS INC net income (loss) available to common stockholders, basic for fiscal 2022 was -$220.29M.
Period endNet Income (Loss) Available to Common Stockholders, Basic 3 monthNet Income (Loss) Available to Common Stockholders, Basic 3 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 6 monthNet Income (Loss) Available to Common Stockholders, Basic 6 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 9 monthNet Income (Loss) Available to Common Stockholders, Basic 9 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 12 monthNet Income (Loss) Available to Common Stockholders, Basic 12 month as first filed
2026-06-30-$604.00K
10-Q · filed 2026-08-07
$38.57M
10-Q · filed 2026-08-07
$27.94M
derived: sum of 3 quarters · filed 2026-08-07
$91.80M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$39.17M
10-Q · filed 2026-05-11
$28.54M
derived: sum of 2 quarters · filed 2026-05-11
$92.40M
derived: sum of 3 quarters · filed 2026-05-11
$64.39M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31-$10.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$53.23M
derived: sum of 2 quarters · filed 2026-03-16
$25.22M
derived: sum of 3 quarters · filed 2026-08-07
-$101.00K
10-K · filed 2026-03-16
2025-09-30$63.86M
10-Q · filed 2025-11-10
$35.85M
derived: sum of 2 quarters · filed 2026-08-07
$10.53M
10-Q · filed 2025-11-10
-$35.38M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30-$28.01M
10-Q · filed 2026-08-07
-$53.33M
10-Q · filed 2026-08-07
-$99.24M
derived: sum of 3 quarters · filed 2026-08-07
-$165.68M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31-$25.32M
10-Q · filed 2026-05-11
-$71.23M
derived: sum of 2 quarters · filed 2026-05-11
-$137.67M
derived: sum of 3 quarters · filed 2026-05-11
-$190.81M
derived: sum of 4 quarters · filed 2026-05-11
2024-12-31-$45.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
-$112.35M
derived: sum of 2 quarters · filed 2026-03-16
-$165.49M
derived: sum of 3 quarters · filed 2026-03-16
-$227.43M
10-K · filed 2026-03-16
2024-09-30-$66.44M
10-Q · filed 2025-11-10
-$119.58M
derived: sum of 2 quarters · filed 2025-11-10
-$181.51M
10-Q · filed 2025-11-10
-$227.86M
derived: sum of 4 quarters · filed 2026-03-16
2024-06-30-$53.13M
10-Q · filed 2025-08-11
-$115.07M
10-Q · filed 2025-08-11
-$161.42M
derived: sum of 3 quarters · filed 2026-03-16
-$223.67M
derived: sum of 4 quarters · filed 2026-03-16
2024-03-31-$61.94M
10-Q · filed 2025-05-12
-$108.28M
derived: sum of 2 quarters · filed 2026-03-16
-$170.54M
derived: sum of 3 quarters · filed 2026-03-16
-$239.61M
derived: sum of 4 quarters · filed 2026-03-16
2023-12-31-$46.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
-$108.60M
derived: sum of 2 quarters · filed 2026-03-16
-$177.67M
derived: sum of 3 quarters · filed 2026-03-16
-$245.97M
10-K · filed 2026-03-16
2023-09-30-$62.25M
10-Q · filed 2024-11-12
-$131.32M
derived: sum of 2 quarters · filed 2024-11-12
-$199.63M
10-Q · filed 2024-11-12
-$270.78M
derived: sum of 4 quarters · filed 2025-03-17
2023-06-30-$69.07M
10-Q · filed 2024-08-08
-$137.38M
10-Q · filed 2024-08-08
-$208.52M
derived: sum of 3 quarters · filed 2025-03-17
-$262.80M
derived: sum of 4 quarters · filed 2025-03-17
2023-03-31-$68.31M
10-Q · filed 2024-05-07
-$139.45M
derived: sum of 2 quarters · filed 2025-03-17
-$193.73M
derived: sum of 3 quarters · filed 2025-03-17
-$240.22M
derived: sum of 4 quarters · filed 2025-03-17
2022-12-31-$71.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17
-$125.42M
derived: sum of 2 quarters · filed 2025-03-17
-$171.91M
derived: sum of 3 quarters · filed 2025-03-17
-$220.29M
10-K · filed 2025-03-17
2022-09-30-$54.27M
10-Q · filed 2023-11-09
-$100.76M
derived: sum of 2 quarters · filed 2023-11-09
-$149.14M
10-Q · filed 2023-11-09
-$214.70M
derived: sum of 4 quarters · filed 2024-03-14
2022-06-30-$46.49M
10-Q · filed 2023-08-08
-$94.86M
10-Q · filed 2023-08-08
-$160.43M
derived: sum of 3 quarters · filed 2024-03-14
$18.07M
derived: sum of 4 quarters · filed 2024-03-14
2022-03-31-$48.38M
10-Q · filed 2023-05-09
-$113.94M
derived: sum of 2 quarters · filed 2024-03-14
$64.56M
derived: sum of 3 quarters · filed 2024-03-14
-$18.79M
derived: sum of 4 quarters · filed 2024-03-14
2021-12-31-$65.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14
$112.94M
derived: sum of 2 quarters · filed 2024-03-14
$29.59M
derived: sum of 3 quarters · filed 2024-03-14
-$24.14M
10-K · filed 2024-03-14
2021-09-30$178.50M
10-Q · filed 2022-11-08
$95.16M
derived: sum of 2 quarters · filed 2022-11-08
$41.43M
10-Q · filed 2022-11-08
$3.77M
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30-$83.34M
10-Q · filed 2022-08-09
-$137.07M
10-Q · filed 2022-08-09
-$174.73M
derived: sum of 3 quarters · filed 2022-08-09
-$225.94M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31-$53.73M
10-Q · filed 2022-05-10
-$91.39M
derived: sum of 2 quarters · filed 2022-05-10
-$142.59M
derived: sum of 3 quarters · filed 2022-05-10
-$190.13M
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31-$37.66M
10-K · filed 2021-03-16
-$88.86M
derived: sum of 2 quarters · filed 2021-11-09
-$136.40M
derived: sum of 3 quarters · filed 2021-11-09
-$181.12M
10-K · filed 2023-03-16
2020-09-30-$51.20M
10-Q · filed 2021-11-09
-$98.74M
derived: sum of 2 quarters · filed 2021-11-09
-$143.46M
10-Q · filed 2021-11-09
-$173.57M
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30-$47.53M
10-Q · filed 2021-08-09
-$92.26M
10-Q · filed 2021-08-09
-$122.36M
derived: sum of 3 quarters · filed 2021-08-09
-$167.89M
derived: sum of 4 quarters · filed 2021-08-09
2020-03-31-$44.73M
10-Q · filed 2021-05-07
-$74.83M
derived: sum of 2 quarters · filed 2021-05-07
-$120.36M
derived: sum of 3 quarters · filed 2021-05-07
-$171.04M
derived: sum of 4 quarters · filed 2021-05-07
2019-12-31-$30.11M
10-K · filed 2021-03-16
-$75.63M
derived: sum of 2 quarters · filed 2021-03-16
-$126.32M
derived: sum of 3 quarters · filed 2021-03-16
-$107.86M
10-K · filed 2022-03-01
2019-09-30-$45.53M
10-K · filed 2021-03-16
-$96.21M
derived: sum of 2 quarters · filed 2021-03-16
-$77.76M
10-Q · filed 2020-11-09
-$125.56M
derived: sum of 4 quarters · filed 2021-03-16
2019-06-30-$50.69M
10-K · filed 2021-03-16
-$32.23M
10-Q · filed 2020-08-10
-$80.04M
derived: sum of 3 quarters · filed 2021-03-16
-$113.22M
derived: sum of 4 quarters · filed 2021-03-16
2019-03-31$18.45M
10-K · filed 2021-03-16
-$29.35M
derived: sum of 2 quarters · filed 2021-03-16
-$62.53M
derived: sum of 3 quarters · filed 2021-03-16
-$87.25M
derived: sum of 4 quarters · filed 2021-03-16
2018-12-31-$47.81M
10-K · filed 2020-03-16
-$80.98M
derived: sum of 2 quarters · filed 2020-03-16
-$105.71M
derived: sum of 3 quarters · filed 2020-03-16
-$159.90M
10-K · filed 2021-03-16
-$159.90M
10-K · filed 2019-03-18
2018-09-30-$33.18M
10-K · filed 2020-03-16
-$33.18M
10-Q · filed 2018-11-07
-$57.90M
derived: sum of 2 quarters · filed 2020-03-16
-$112.09M
10-Q · filed 2019-11-07
-$112.09M
10-Q · filed 2018-11-07
-$147.18M
derived: sum of 4 quarters · filed 2020-03-16
2018-06-30-$24.72M
10-K · filed 2020-03-16
-$24.72M
10-Q · filed 2018-08-09
-$78.92M
10-Q · filed 2019-08-09
-$78.91M
10-Q · filed 2018-08-09
-$114.00M
derived: sum of 3 quarters · filed 2020-03-16
-$150.90M
derived: sum of 4 quarters · filed 2020-03-16
2018-03-31-$54.19M
10-K · filed 2020-03-16
-$54.19M
10-Q · filed 2018-05-10
-$89.28M
derived: sum of 2 quarters · filed 2020-03-16
-$126.17M
derived: sum of 3 quarters · filed 2020-03-16
-$157.94M
derived: sum of 4 quarters · filed 2020-03-16
2017-12-31-$35.09M
10-K · filed 2019-03-18
-$71.98M
derived: sum of 2 quarters · filed 2019-03-18
-$103.74M
derived: sum of 3 quarters · filed 2019-03-18
-$120.90M
10-K · filed 2020-03-16
-$120.90M
10-K · filed 2018-03-16
2017-09-30-$36.89M
10-K · filed 2019-03-18
-$36.89M
10-Q · filed 2017-11-07
-$68.66M
derived: sum of 2 quarters · filed 2019-03-18
-$85.81M
10-Q · filed 2018-11-07
-$111.98M
derived: sum of 4 quarters · filed 2019-03-18
2017-06-30-$31.76M
10-K · filed 2019-03-18
-$31.76M
10-Q · filed 2017-08-07
-$48.92M
10-Q · filed 2018-08-09
-$75.09M
derived: sum of 3 quarters · filed 2019-03-18
-$115.92M
derived: sum of 4 quarters · filed 2019-03-18
2017-03-31-$17.15M
10-K · filed 2019-03-18
-$17.15M
10-Q · filed 2017-05-04
-$43.33M
derived: sum of 2 quarters · filed 2019-03-18
-$84.15M
derived: sum of 3 quarters · filed 2019-03-18
-$112.52M
derived: sum of 4 quarters · filed 2019-03-18
2016-12-31-$26.17M
10-K · filed 2018-03-16
-$67.00M
derived: sum of 2 quarters · filed 2018-03-16
-$95.37M
derived: sum of 3 quarters · filed 2018-03-16
-$127.20M
10-K · filed 2019-03-18
2016-09-30-$40.83M
10-K · filed 2018-03-16
-$40.82M
10-Q · filed 2016-11-09
-$69.20M
derived: sum of 2 quarters · filed 2018-03-16
-$101.02M
10-Q · filed 2017-11-07
-$116.68M
derived: sum of 4 quarters · filed 2018-03-16
2016-06-30-$28.37M
10-K · filed 2018-03-16
-$28.37M
10-Q · filed 2016-08-04
-$60.20M
10-Q · filed 2017-08-07
-$75.86M
derived: sum of 3 quarters · filed 2018-03-16
-$89.03M
derived: sum of 4 quarters · filed 2018-03-16
2016-03-31-$31.83M
10-K · filed 2018-03-16
-$31.83M
10-Q · filed 2016-05-09
-$47.49M
derived: sum of 2 quarters · filed 2018-03-16
-$60.66M
derived: sum of 3 quarters · filed 2018-03-16
-$101.12M
derived: sum of 4 quarters · filed 2018-03-16
2015-12-31-$15.66M
10-K · filed 2017-03-16
-$28.83M
derived: sum of 2 quarters · filed 2017-03-16
-$69.29M
derived: sum of 3 quarters · filed 2017-03-16
-$88.08M
10-K · filed 2018-03-16
2015-09-30-$13.17M
10-K · filed 2017-03-16
-$13.17M
10-Q · filed 2015-11-04
-$53.63M
derived: sum of 2 quarters · filed 2017-03-16
-$72.43M
10-Q · filed 2016-11-09
-$98.45M
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30-$40.46M
10-K · filed 2017-03-16
-$40.46M
10-Q · filed 2015-08-03
-$59.25M
10-Q · filed 2016-08-04
-$85.28M
derived: sum of 3 quarters · filed 2017-03-16
-$93.44M
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31-$18.79M
10-K · filed 2017-03-16
-$18.79M
10-Q · filed 2015-05-01
-$44.82M
derived: sum of 2 quarters · filed 2017-03-16
-$52.98M
derived: sum of 3 quarters · filed 2017-03-16
-$61.07M
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31-$26.03M
10-K · filed 2016-03-15
-$34.19M
derived: sum of 2 quarters · filed 2016-03-15
-$42.28M
derived: sum of 3 quarters · filed 2016-03-15
-$42.69M
10-K · filed 2017-03-16
2014-09-30-$8.16M
10-K · filed 2016-03-15
-$8.16M
10-Q · filed 2014-10-31
-$16.25M
derived: sum of 2 quarters · filed 2016-03-15
-$16.66M
10-Q · filed 2015-11-04
-$22.49M
derived: sum of 4 quarters · filed 2016-03-15
2014-06-30-$8.09M
10-K · filed 2016-03-15
-$7.81M
10-Q · filed 2014-08-01
-$8.50M
10-Q · filed 2015-08-03
-$14.33M
derived: sum of 3 quarters · filed 2016-03-15
-$21.70M
derived: sum of 4 quarters · filed 2016-03-15
2014-03-31-$409.00K
10-K · filed 2016-03-15
-$408.54K
10-Q · filed 2014-05-09
-$6.24M
derived: sum of 2 quarters · filed 2016-03-15
-$13.61M
derived: sum of 3 quarters · filed 2016-03-15
-$24.80M
derived: sum of 4 quarters · filed 2016-03-15
2013-12-31-$5.83M
10-K · filed 2015-03-16
-$13.20M
derived: sum of 2 quarters · filed 2015-03-16
-$24.39M
derived: sum of 3 quarters · filed 2015-03-16
-$33.23M
10-K · filed 2016-03-15
2013-09-30-$7.37M
10-K · filed 2015-03-16
-$7.37M
10-Q · filed 2013-11-08
-$18.56M
derived: sum of 2 quarters · filed 2015-03-16
-$27.40M
10-Q · filed 2014-10-31
-$33.04M
derived: sum of 4 quarters · filed 2015-03-16
2013-06-30-$11.19M
10-K · filed 2015-03-16
-$11.19M
10-Q · filed 2013-08-09
-$20.03M
10-Q · filed 2014-08-01
-$25.67M
derived: sum of 3 quarters · filed 2015-03-16
-$31.60M
derived: sum of 4 quarters · filed 2015-03-16
2013-03-31-$8.84M
10-K · filed 2015-03-16
-$8.84M
10-Q · filed 2013-05-10
-$14.48M
derived: sum of 2 quarters · filed 2015-03-16
-$20.41M
derived: sum of 3 quarters · filed 2015-03-16
-$27.53M
derived: sum of 4 quarters · filed 2015-03-16
2012-12-31-$5.64M
10-K · filed 2014-03-07
-$11.57M
derived: sum of 2 quarters · filed 2014-03-07
-$18.69M
derived: sum of 3 quarters · filed 2014-03-07
-$12.12M
10-K · filed 2015-03-16
2012-09-30-$5.93M
10-K · filed 2014-03-07
-$5.93M
10-Q · filed 2012-11-07
-$13.05M
derived: sum of 2 quarters · filed 2014-03-07
-$6.48M
10-Q · filed 2013-11-08
-$12.70M
derived: sum of 4 quarters · filed 2014-03-07
2012-06-30-$7.12M
10-K · filed 2014-03-07
-$7.12M
10-Q · filed 2012-08-08
-$550.61K
10-Q · filed 2013-08-09
-$6.77M
derived: sum of 3 quarters · filed 2014-03-07
-$12.50M
derived: sum of 4 quarters · filed 2014-03-07
2012-03-31$6.57M
10-K · filed 2014-03-07
$6.57M
10-Q · filed 2012-05-09
$353.00K
derived: sum of 2 quarters · filed 2014-03-07
-$5.38M
derived: sum of 3 quarters · filed 2014-03-07
-$11.34M
derived: sum of 4 quarters · filed 2014-03-07
2011-12-31-$6.22M
10-K · filed 2013-03-18
-$11.95M
derived: sum of 2 quarters · filed 2013-03-18
-$17.91M
derived: sum of 3 quarters · filed 2013-03-18
-$24.07M
10-K · filed 2014-03-07
2011-09-30-$5.73M
10-K · filed 2013-03-18
-$5.73M
10-Q · filed 2011-11-04
-$11.69M
derived: sum of 2 quarters · filed 2013-03-18
-$17.85M
10-Q · filed 2012-11-07
-$20.46M
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30-$5.96M
10-K · filed 2013-03-18
-$5.96M
10-Q · filed 2011-08-05
-$12.12M
10-Q · filed 2012-08-08
-$14.73M
derived: sum of 3 quarters · filed 2013-03-18
-$20.64M
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31-$6.16M
10-K · filed 2013-03-18
-$6.16M
10-Q · filed 2012-05-09
-$8.77M
derived: sum of 2 quarters · filed 2013-03-18
-$14.68M
derived: sum of 3 quarters · filed 2013-03-18
-$19.85M
derived: sum of 4 quarters · filed 2013-03-18
2010-12-31-$2.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
-$8.52M
derived: sum of 2 quarters · filed 2013-03-18
-$13.69M
derived: sum of 3 quarters · filed 2013-03-18
-$22.70M
10-K · filed 2013-03-18
2010-09-30-$5.91M
10-Q · filed 2011-11-04
-$11.07M
derived: sum of 2 quarters · filed 2011-11-04
-$20.08M
10-Q · filed 2011-11-04
2010-06-30-$5.17M
10-Q · filed 2011-08-05
-$14.18M
10-Q · filed 2011-08-05
2009-12-31-$31.11M
10-K · filed 2012-03-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60